To read the full story, subscribe or sign in.

Gendius working with Astrazeneca to improve diabetes care via its Intellin system

June 30, 2020

LONDON – Digital health startup Gendius Ltd. is to take a lead role in an Astrazeneca plc initiative to improve diabetes care in the Gulf states, after signing an agreement to deploy its Intellin diabetes management system in the region.

BioWorld MedTech Diabetes Digital health Europe Middle East North Africa

Today's news in brief

BioWorld

BioWorld briefs for Nov. 7, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 7, 2024.

Regulatory actions for Oct. 31, 2024

BioWorld

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...

Australia reimburses Vazkepa a decade after US approval

BioWorld

For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity

BioWorld

After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...